Cationic drugs and COVID-19.

Int J Immunopathol Pharmacol

Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.

Published: October 2020

Given the sharp spreading of COVID-19 pandemic all around the world, our attention was brought to consider that that many cationic drugs (i.e. those characterized by the presence, at physiological pH value, of one or more cationic groups, both primary, secondary, tertiary and guanidinic aminic groups) could have any effect in impairing SARS-CoV2 entry in the host cell. This could open to new therapeutic chances against COVID-19.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7557649PMC
http://dx.doi.org/10.1177/2058738420966078DOI Listing

Publication Analysis

Top Keywords

cationic drugs
8
drugs covid-19
4
covid-19 sharp
4
sharp spreading
4
spreading covid-19
4
covid-19 pandemic
4
pandemic attention
4
attention brought
4
brought consider
4
consider cationic
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!